Introduction
Between January 2011 and July 2014, we performed a Randomized Controlled Trial (RCT) in carriers of methicillin-resistant Staphylococcus aureus (MRSA) to test the efficacy of polyhexanide versus a placebo solution for MRSA decolonization.
Objectives
We assessed determinants associated with successful MRSA decolonization among patients included in this RCT.
Methods
We conducted a retrospective, unmatched case-control study among MRSA-positive patients treated by polyhexanide or placebo and a MRSA screening swab at day 28 after the end of the treatment. Cases were defined as patients with a negative MRSA screening at the end of the study. The control group consisted of patients still MRSApositive at the end of the study. We tested potential promoting factors using univariate logistic regression analysis. Data were recorded prospectively during the initial RCT with the consent of the patients. A multivariate logistic regression model was then built. We kept as potential candidates for the multivariate analysis promoting factors with a p-value < 0.2. The resulting model was verified using the Hosmer-Lemeshow test. 
Results

Conclusion
Independent patients with only 1 MRSA-positive body site at baseline (nose or groin) are more likely to be successfully decolonized.
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